HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aranya Bagchi Selected Research

Aranya Bagchi Research Topics

Disease

6Inflammation (Inflammations)
01/2022 - 03/2007
5Sepsis (Septicemia)
01/2011 - 03/2005
3Pulmonary Atelectasis
01/2022 - 01/2018
3Obesity
07/2021 - 01/2020
2Pneumonia (Pneumonitis)
12/2022 - 02/2008
2Acute Lung Injury
12/2022 - 01/2022
2Respiratory Insufficiency (Respiratory Failure)
07/2021 - 02/2008
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2021 - 01/2021
2Hypoxia (Hypoxemia)
01/2021 - 02/2008
2Critical Illness (Critically Ill)
01/2021 - 01/2017
2Vascular Calcification
11/2019 - 01/2016
2Atherosclerosis
01/2019 - 01/2016
2Heart Arrest (Cardiac Arrest)
01/2019 - 01/2016
2Brain Injuries (Brain Injury)
01/2019 - 01/2016
2Infections
08/2007 - 01/2007
1Pulmonary Edema
12/2022
1Poisoning
01/2022
1Anemia
01/2022
1Iron Overload
01/2022
1Emergence Delirium
01/2021
1COVID-19
01/2021
1Leigh Disease (Leigh's Disease)
01/2021
1Thrombophilia
01/2021
1Hyperoxia
01/2021
1Atrophy
04/2020
1Hypertension (High Blood Pressure)
01/2018
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
12/2017
1Atherosclerotic Plaque (Atheroma)
01/2016
1Vascular Diseases (Vascular Disease)
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
01/2016
1Pulmonary Hypertension
03/2012
1Leukopenia
02/2008
1Weight Loss (Weight Reduction)
02/2008
1Viremia
08/2007
1Blister (Bulla)
09/2006
1Burns
09/2006
1Peritonitis
09/2006

Drug/Important Bio-Agent (IBA)

3IronIBA
01/2022 - 01/2017
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2016
3LipopolysaccharidesIBA
01/2022 - 02/2008
2Oxygen (Dioxygen)IBA
01/2022 - 12/2017
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2LipidsIBA
01/2016 - 09/2006
2N- palmitoyl- S- (2,3- bis(palmitoyloxy)propyl)cysteinyl- seryl- lysyl- lysyl- lysyl- lysineIBA
01/2011 - 02/2008
2Lipoproteins (Lipoprotein)IBA
01/2011 - 03/2007
2Peptidoglycan (Murein)IBA
01/2011 - 03/2007
2Toll-Like Receptors (Toll-Like Receptor)IBA
02/2008 - 03/2005
2Toll-Like Receptor 2IBA
03/2007 - 09/2006
2Membrane Proteins (Integral Membrane Proteins)IBA
03/2007 - 09/2006
1AldehydesIBA
12/2022
1AerosolsIBA
12/2022
1UbiquitinIBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Chemokine CCL5IBA
01/2022
1Niacin (Nicotinic Acid)FDA LinkGeneric
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1NAD (NADH)IBA
01/2021
1Matrix Gla ProteinIBA
11/2019
1HepcidinsIBA
01/2019
1glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA
01/2019
1NitrogenIBA
01/2018
1Atrial Natriuretic Factor (ANF)IBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Superoxides (Superoxide)IBA
01/2017
1Oxidoreductases (Dehydrogenase)IBA
01/2016
1Pyruvic Acid (Pyruvate)IBA
01/2016
1Thiamine (Aneurin)FDA Link
01/2016
1Neuroprotective AgentsIBA
01/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012
1GasesIBA
02/2008
1LigandsIBA
08/2007
1Toll-Like Receptor AgonistsIBA
01/2007
1Inflammation MediatorsIBA
01/2007
1Monoclonal AntibodiesIBA
09/2006
1FibrinIBA
09/2006
1Immunoglobulin G (IgG)IBA
09/2006

Therapy/Procedure

5Artificial Respiration (Mechanical Ventilation)
07/2021 - 01/2020
2Length of Stay
07/2021 - 01/2021
2Therapeutics
01/2021 - 01/2016
2Cardiopulmonary Resuscitation (CPR)
01/2019 - 01/2016
1Extracorporeal Membrane Oxygenation
07/2021
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2021
1Resuscitation
01/2019
1Decompression
01/2018
1Blood Transfusion (Blood Transfusions)
01/2017
1Highly Active Antiretroviral Therapy (HAART)
08/2007
1Ligation
09/2006
1Punctures
09/2006